Research Site

JinJoo 52727

1 studies enrolling now · 2 studies all time

What they study most

Non-small Cell Lung Cancer, Paroxysmal Nocturnal Hemoglobinuria (PNH)

Studies at this site

• A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) — Recruiting now
• ALXN1210 (Ravulizumab) Versus Eculizumab in Complement Inhibitor Treatment-Naïve Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) — Completed